Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04554264

Complicated Grief in ICU in the Aftermath of COVID-19

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

An increased proportion of deaths occur in the intensive care unit (ICU). Some amenable factors such as end-of-life practices may contribute to complicated grief. Because of the COVID-19 pandemic, visitor restrictions in health care facilities have been implemented. Families were also unable to implement usual funerals. The investigators hypothesize that these policies and practices may impact grief during covid-19 pandemic. The aim of this study is to evaluate the prevalence of complicated grief after death of a relative in the ICU during the COVID-19 pandemic.

Conditions

Interventions

TypeNameDescription
OTHERquestionnaireInventory of Complicate Grief (ICG) score in relative from patients who died in ICU after SARS-Cov2 infection. This is the most commonly used assessment tool for complicated grief which focuses on different symptoms than depression or anxiety. A score \> 25 indicate complicated grief.

Timeline

Start date
2020-09-01
Primary completion
2021-09-01
Completion
2022-09-01
First posted
2020-09-18
Last updated
2023-03-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04554264. Inclusion in this directory is not an endorsement.